MedPath

MRI in Diagnosing and Monitoring CIDP

Completed
Conditions
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Registration Number
NCT02017769
Lead Sponsor
University of Aarhus
Brief Summary

We want to study whether MRI can be useful in diagnosing and monitoring patients with CIDP in maintenance treatment with immunoglobulin

Detailed Description

Chronic inflammatory neuropathies such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can be successfully treated with immunoglobulin either intravenously (IVIG) or subcutaneously (SCIG).

CIDP is diagnosed by electrophysiology which is time-consuming and unpleasant for the patient.

New techniques suggest that Magnetic Resonance Imaging (MRI) and ultrasound imaging can be used to detect injuries in the peripheral nerves

We want to study if MRI and ultrasound is able to detect damages in peripheral nerves, nerve roots and plexus in patients with CIDP.

Moreover, we want to compare these findings to healthy matched controls and to see if treatment with immunoglobulin changes findings in MRI

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria

CIDP patients

  • Age > 18 and < 80 years
  • Diagnosed with definite and probable CIDP and fulfilling the European Federation of Neurological Sciences/Peripheral Nerve Society (EFNS/PNS) criteria

Healthy controls

  • Age > 18 and < 80 years
  • No neurological disorders
Read More
Exclusion Criteria
  • Age < 18 or > 80 years
  • Contraindications to MRI
  • Pregnancy
  • Other cause of neuropathy (incl. pressure neuropathy)
  • Diabetes mellitus
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DTI changes in nerves and musclesAt enrolment

Diffusion Tension Imaging (DTI) in peripheral nerves and muscles in the lower extremities in CIDP patients treated with SCIG will be compared to healthy controls

Secondary Outcome Measures
NameTimeMethod
Comparing clinical findings to MRIAt enrolment

Clinical evaluation by:

Isokinetic dynamometry Clinical MRC score

These findings wil be compared to findings on MRI to assess an eventual correlation

Changes in MRI findings between treated and untreated CIDP patientsAll patients are examined at enrolment. Untreated patients are re-examined after 4 months of treatment

Comparing changes in MTR and DTI between CIDP patients treated with subcutaneous immunoglobulin to those untreated.

The untreated patients will be examined again after 4 months of treatment with immunoglobulin

Trial Locations

Locations (1)

Department of Neurology, Aarhus University Hospital

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath